Kynurenines in the mammalian brain: when physiology meets pathology

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

Ido expression by dendritic cells: tolerance and tryptophan catabolism

Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341 · see citing works

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898 · see citing works

Mammalian nicotinic acetylcholine receptors: from structure to function

Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724 · see citing works

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682 · see citing works

Microglia in neurodegenerative disease

Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · see citing works

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

Anis, N. A., Berry, S. C., Burton, N. R., & Lodge, D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11031.x · Cited by 1,399 · see citing works

Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain

Schwarcz, R. M., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,269 · see citing works

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

Coyle, J. T., & Schwarcz, R. M. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,255 · see citing works

Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review

Potvin, S., Stip, É., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, É. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 989 · see citing works

Neuropharmacology of quinolinic and kynurenic acids.

Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 949 · see citing works

Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

Lahti, A. C., Koffel, B., LaPorte, D. J., & Tamminga, C. A. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 921 · see citing works

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid

Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849 · see citing works

Autism‐like behavioral phenotypes in BTBR T+tf/J mice

McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812 · see citing works

The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

Hilmas, C., Pereira, E., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 772 · see citing works

Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

Fukui, S., Schwarcz, R. M., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 765 · see citing works

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751 · see citing works

Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35

Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J. D., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 691 · see citing works

QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NON-INFLAMMATORY NEUROLOGICAL DISEASE

Heyes, M. P., Saito, K., Crowley, J. S., DAVIS, L. E., Demitrack, M. A., Der, M. G., Dilling, L. A., Elia, J., Kruesi, M. J. P., Lackner, A. A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 682 · see citing works

Hypoglycemia-Induced Neuronal Damage Prevented by an N -Methyl-D-Aspartate Antagonist

Wieloch, T. W. (1985) · Science · doi:10.1126/science.2996146 · Cited by 674 · see citing works

Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling

DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 631 · see citing works

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression

Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630 · see citing works

Increased cortical kynurenate content in schizophrenia

Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590 · see citing works

Kynurenine Pathway Metabolites in Humans: Disease and Healthy States

Chen, Y.-Q., & Guillemin, G. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2097 · Cited by 589 · see citing works

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Pilotte, L., Larrieu, P., Stroobant, V., Colau, D., Dolušić, E., Frédérick, R., Plaen, E. D., Uyttenhove, C., Wouters, J., Masereel, B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113873109 · Cited by 576 · see citing works

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?

Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568 · see citing works

Elaborate interactions between the immune and nervous systems

Steinman, L. (2004) · Nature Immunology · doi:10.1038/ni1078 · Cited by 556 · see citing works

Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities

Schwarcz, R. M., & Pellicciari, R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556 · see citing works

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru‐Lamoury, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 541 · see citing works

Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions

Tynan, R. J., Naicker, S., Hinwood, M., Nalivaiko, E., Buller, K. M., Pow, D. V., Day, T. A., & Walker, F. R. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.02.001 · Cited by 531 · see citing works

Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration

Zwilling, D., Huang, S., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H., Lee, J. H., Truong, J. K., Andrews-Zwilling, Y. S., Hsieh, E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.020 · Cited by 519 · see citing works

Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guérin

O’Connor, J. C., André, C., Wang, Y., Lawson, M. A., Szegedi, S. S., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5032-08.2009 · Cited by 498 · see citing works

Interferon-alpha–induced changes in tryptophan metabolism

Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493 · see citing works

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.

Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 478 · see citing works

3‐Hydroxykynurenine, an Endogenous Oxidative Stress Generator, Causes Neuronal Cell Death with Apoptotic Features and Region Selectivity

Okuda, S., Nishiyama, N., Saitō, H., & Katsuki, H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010299.x · Cited by 465 · see citing works

Human macrophages convert l -tryptophan into the neurotoxin quinolinic acid

Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 448 · see citing works

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

Wang, Y., Liu, H., McKenzie, G. A., Witting, P. K., Stasch, J., Hahn, M. G., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446 · see citing works

II: Excitotoxic models for neurodegenerative disorders

Schwarcz, R., Foster, A., French, E., Whetsell, W., & Köhler, C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90148-6 · Cited by 442 · see citing works

Microglial activation in presymptomatic Huntington's disease gene carriers

Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. (2007) · Brain · doi:10.1093/brain/awm044 · Cited by 440 · see citing works

Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid

Foster, A. C., Vezzani, A., French, E. D., & Schwarcz, R. M. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90050-8 · Cited by 435 · see citing works

Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment

Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434 · see citing works

Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis

Zunszain, P. A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A. M., Thuret, S., Price, J., & Pariante, C. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.277 · Cited by 388 · see citing works

Glutamate-based antidepressants: 20 years on

Skolnick, P., Popik, P., & Trullás, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.09.002 · Cited by 382 · see citing works

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

Moroni, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00196-x · Cited by 347 · see citing works

On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress

Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.07.002 · Cited by 346 · see citing works

Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases.

Christen, S., Peterhans, E., & Stocker, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2506 · Cited by 336 · see citing works

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

Linderholm, K., Skogh, E., Olsson, S., Dahl, M., Holtze, M., Engberg, G., Samuelsson, M., & Erhardt, S. (2012) · Schizophrenia bulletin · doi:10.1093/schbul/sbq086 · Cited by 335 · see citing works

Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus

Guillemin, G., Brew, B., Noonan, C. E., Takikawa, O., & Cullen, K. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 331 · see citing works

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., & Muchowski, P. J. (2005) · Nature Genetics · doi:10.1038/ng1542 · Cited by 325 · see citing works

Characterization of the Kynurenine Pathway in Human Neurons

Guillemin, G. J., Cullen, K. M., Lim, C. K., Smythe, G. A., Garner, B., Kapoor, V., Takikawa, O., & Brew, B. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4101-07.2007 · Cited by 325 · see citing works

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.

Birch, P., Grossman, C., & Hayes, A. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90367-6 · Cited by 324 · see citing works

l-Kynurenine Its synthesis and possible regulatory function in brain

G�l, E. M., & Sherman, A. D. (1980) · Neurochemical Research · doi:10.1007/bf00964611 · Cited by 318 · see citing works

Kynurenine pathway abnormalities in Parkinson's disease

Ogawa, T., Matson, W. R., Beal, M. F., Myers, R. H., Bird, E. D., Milbury, P. E., & Saso, S. (1992) · Neurology · doi:10.1212/wnl.42.9.1702 · Cited by 317 · see citing works

Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies

Murrough, J. W., Iacoviello, B., Neumeister, A., Charney, D. S., & Iosifescu, D. V. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.06.006 · Cited by 307 · see citing works

Induction of IDO by Bacille Calmette-Guérin Is Responsible for Development of Murine Depressive-Like Behavior

O'Connor, J., Lawson, M., André, C., Briley, E. M., Szegedi, S., Lestage, J., Castanon, N., Herkenham, M., Dantzer, R., & Kelley, K. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0802722 · Cited by 305 · see citing works

Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders

Goto, Y., Yang, C. R., & Otani, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.026 · Cited by 305 · see citing works

Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal

Hanson, N. D., Owens, M. J., & Nemeroff, C. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.220 · Cited by 302 · see citing works

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase.

Cady, S. G., & Sono, M. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90142-6 · Cited by 298 · see citing works

Presence of Kynurenic Acid in the Mammalian Brain

Moroni, F., Russi, P., Lombardi, G., Beni, M. H. H., & Carla�, V. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04852.x · Cited by 279 · see citing works

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway

Ball, H. J., Yuasa, H. J., Austin, C., Weiser, S., & Hunt, N. H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.005 · Cited by 275 · see citing works

Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

Baban, B., Chandler, P., McCool, D. J., Marshall, B., Munn, D. H., & Mellor, A. L. (2004) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2003.11.003 · Cited by 275 · see citing works

Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice

Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., & Nakamura, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-8 · Cited by 273 · see citing works

Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

Rı́os, C., & Santamarı́a, A. (1991) · Neurochemical Research · doi:10.1007/bf00966592 · Cited by 272 · see citing works

Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression

Si, X., Miguel-Hidalgo, J. J., O'Dwyer, G., Stockmeier, C. A., & Rajkowska, G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300525 · Cited by 268 · see citing works

The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease

Campesan, S., Green, E. W., Breda, C., Sathyasaikumar, K. V., Muchowski, P. J., Schwarcz, R. M., Kyriacou, C. P., & Giorgini, F. (2011) · Current Biology · doi:10.1016/j.cub.2011.04.028 · Cited by 261 · see citing works

Human microglia convert l -tryptophan into the neurotoxin quinolinic acid

Heyes, M. P., Achim, C. L., Wiley, C. A., Major, E. O., Saito, K., & Markey, S. P. (1996) · Biochemical Journal · doi:10.1042/bj3200595 · Cited by 260 · see citing works

Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease

GUIDETTI, P., Luthi‐Carter, R., Augood, S. J., & Schwarcz, R. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.006 · Cited by 259 · see citing works

Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors

Swartz, K., During, M. J., Freese, A. B., & Beal, M. F. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02965.1990 · Cited by 258 · see citing works

The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons

Rahman, A., Ting, K., Cullen, K. M., Braidy, N., Brew, B. J., & Guillemin, G. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006344 · Cited by 257 · see citing works

Presynaptic kynurenate‐sensitive receptors inhibit glutamate release

Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., & Moroni, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01592.x · Cited by 254 · see citing works

Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia

Sathyasaikumar, K. V., Stachowski, E. K., Wonodi, I., Roberts, R. C., Rassoulpour, A., McMahon, R. P., & Schwarcz, R. M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq112 · Cited by 253 · see citing works

Structure, expression, and function of kynurenine aminotransferases in human and rodent brains

Han, Q., Cai, T., Tagle, D. A., & Li, J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0166-4 · Cited by 240 · see citing works

Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder

Miller, C. L., Llenos, I. C., Dulay, J. R., & Weis, S. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.056 · Cited by 240 · see citing works

Reduction of Endogenous Kynurenic Acid Formation Enhances Extracellular Glutamate, Hippocampal Plasticity, and Cognitive Behavior

Potter, M., Elmer, G., Bergeron, R., Albuquerque, E. X., Guidetti, P., Wu, H., & Schwarcz, R. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.39 · Cited by 235 · see citing works

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia

Miller, C. L., Llenos, I. C., Dulay, J. R., Barillo, M. M., Yolken, R. H., & Weis, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.015 · Cited by 232 · see citing works

Expression of The Kynurenine Pathway Enzymes in Human Microglia and Macrophages

Guillemin, G. J., Smith, D. G., Smythe, G. A., Armati, P. J., & Brew, G. J. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_12 · Cited by 229 · see citing works

Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis

Sakurai, K., Zou, J.-P., Tschetter, J. R., Ward, J. M., & Shearer, G. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00176-5 · Cited by 227 · see citing works

Elevations of Endogenous Kynurenic Acid Produce Spatial Working Memory Deficits

Chess, A. C., Simoni, M. K., Alling, T. E., & Bucci, D. J. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl033 · Cited by 225 · see citing works

Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model

Yue, E. W., Douty, B. D., Wayland, B. R., Bower, M. J., Liu, X., Leffet, L., Wang, Q., Bowman, K., Hansbury, M., Liu, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900518f · Cited by 221 · see citing works

Identification and quantification of kynurenic acid in human brain tissue

Turski, W. A., Nakamura, M., Todd, W. P., Carpenter, B. K., Whetsell, W. O., & Schwarcz, R. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)90815-3 · Cited by 220 · see citing works

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

Beal, M. F., Matson, W. R., Storey, E., Milbury, P. E., Ryan, E. A., Ogawa, T., & Bird, E. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90191-m · Cited by 220 · see citing works

Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.

Thomas, S. R., & Stocker, R. (1999) · Redox Report · doi:10.1179/135100099101534927 · Cited by 220 · see citing works

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

Müller, N., & Schwarz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033242 · Cited by 214 · see citing works

Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-γ?

Connor, T. J., Starr, N., O’Sullivan, J. B., & Harkin, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.007 · Cited by 213 · see citing works

Synthesis and Biochemical Evaluation ofN-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase

Röver, S., Cesura, A. M., Huguenin, P. N., Kettler, R., & Szente, A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970467t · Cited by 212 · see citing works

3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Generate Hydrogen Peroxide and Promote α-Crystallin Cross-Linking by Metal Ion Reduction

Goldstein, L. E., Leopold, M. C., Huang, X., Atwood, C., Saunders, A. J., Hartshorn, M. A., Lim, J. T., Faget, K. Y., Muffat, J., Scarpa, R. C., et al. (2000) · Biochemistry · doi:10.1021/bi992997s · Cited by 212 · see citing works

Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.

Parsons, C., Danysz, W., Quack, G. ̈., Hartmann, S., Lorenz, B., Wollenburg, C., Baran, L., Przegaliński, E., Kostowski, W., Krza̧ścik, P., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37160-5 · Cited by 207 · see citing works

Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery

Moroni, F., Cozzi, A., Sili, M., & Mannaioni, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0763-x · Cited by 203 · see citing works

Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation

Maes, M. H. J., Verkerk, R. M., Bonaccorso, S., Ombelet, W. U. A. M., Bosmans, E., & Scharpé, S. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01853-2 · Cited by 203 · see citing works

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.

Saito, K., Markey, S., & Heyes, M. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90467-g · Cited by 196 · see citing works

Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice

Lapin, I. P. (1978) · Journal of Neural Transmission · doi:10.1007/bf01262727 · Cited by 193 · see citing works

Endogenous kynurenic acid disrupts prepulse inhibition.

Erhardt, S., Schwieler, L., Emanuelsson, C., & Geyer, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.006 · Cited by 187 · see citing works

Regulation of the Kynurenine Metabolic Pathway by Interferon‐γ in Murine Cloned Macrophages and Microglial Cells

Alberati‐Giani, D., Ricciardi‐Castagnoli, P., Köhler, C., & Cesura, A. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66030996.x · Cited by 187 · see citing works

3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum

Guidetti, P., & Schwarcz, R. M. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00806.x · Cited by 180 · see citing works

Kynurenine Pathway Enzymes in Dendritic Cells Initiate Tolerogenesis in the Absence of Functional IDO

Belladonna, M. L., Grohmann, U., Guidetti, P., Volpi, C., Bianchi, R., Fioretti, M. C., Schwarcz, R. M., Fallarino, F., & Puccetti, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.130 · Cited by 180 · see citing works

Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system

Whetsell, W. O., & Schwarcz, R. M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90609-5 · Cited by 176 · see citing works

Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

Rassoulpour, A., Wu, H., Ferré, S., & Schwarcz, R. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03134.x · Cited by 174 · see citing works

Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory

Pocivavsek, A., Wu, H., Potter, M., Elmer, G., Pellicciari, R., & Schwarcz, R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.127 · Cited by 171 · see citing works

Quantitative aspects of tryptophan metabolism in humans and other species: a review.

Leklem, J. (1971) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/24.6.659 · Cited by 169 · see citing works

Mechanism of Delayed Increases in Kynurenine Pathway Metabolism in Damaged Brain Regions Following Transient Cerebral Ischemia

Saito, K., Nowak, T. S., Markey, S. P., & Heyes, M. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05836.x · Cited by 167 · see citing works

Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice

Guidetti, P., Bates, G. P., Graham, R. K., Hayden, M. R., Leavitt, B. R., MacDonald, M. E., Slow, E., Wheeler, V. C., Woodman, B., & Schwarcz, R. M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.011 · Cited by 166 · see citing works

Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes

Wonodi, I., Stine, O. C., Sathyasaikumar, K. V., Roberts, R. C., Mitchell, B. D., Hong, L. E., Kajii, Y., Thaker, G. K., & Schwarcz, R. M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.71 · Cited by 166 · see citing works

Mitochondrial aspartate aminotransferase: a third kynurenate‐producing enzyme in the mammalian brain

Guidetti, P., Amori, L., Sapko, M. T., Okuno, E., & Schwarcz, R. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04556.x · Cited by 166 · see citing works

Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities

Carpenedo, R., Chiarugi, A., Russi, P., Lombardi, G., Carla�, V., Pellicciari, R., Mattoli, L., & Moroni, F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90227-5 · Cited by 159 · see citing works

Kynurenine Hydroxylase Inhibitors Reduce Ischemic Brain Damage: Studies with ( m -Nitrobenzoyl)-Alanine (mNBA) and 3,4-Dimethoxy-[-N-4-(Nitrophenyl)Thiazol-2YL]-Benzenesulfonamide (Ro 61-8048) in Models of Focal or Global Brain Ischemia

Cozzi, A., Carpenedo, R., & Moroni, F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199907000-00007 · Cited by 159 · see citing works

Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry

Guidetti, P., Hoffman, G. E., Meléndez‐Ferro, M., Albuquerque, E. X., & Schwarcz, R. M. (2006) · Glia · doi:10.1002/glia.20432 · Cited by 156 · see citing works

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

Pearson, S. J., & Reynolds, G. P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90749-w · Cited by 155 · see citing works

On the relationship between the two branches of the kynurenine pathway in the rat brainin vivo

Amori, L., Guidetti, P., Pellicciari, R., Kajii, Y., & Schwarcz, R. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05893.x · Cited by 151 · see citing works

The Astrocyte-Derived α7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex

Wu, H., Pereira, E. F. R., Bruno, J. P., Pellicciari, R., Albuquerque, E. X., & Schwarcz, R. M. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9235-2 · Cited by 146 · see citing works

THE ENDOGENEOUS AGONIST QUINOLINIC ACID AND THE NON ENDOGENOUS HOMOQUINOLINIC ACID DISCRIMINATE BETWEEN NMDAR2 RECEPTOR SUBUNITS

de Carvalho, L. P., Bochet, P., & Rossier, J. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00091-7 · Cited by 142 · see citing works

Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine

Alexander, K., Wu, H., Schwarcz, R. M., & Bruno, J. P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2539-2 · Cited by 142 · see citing works

The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes

Salter, M., & Pogson, C. I. (1985) · Biochemical Journal · doi:10.1042/bj2290499 · Cited by 134 · see citing works

Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex

Kerr, S. J., Armati, P. J., Guillemin, G. J., & Brew, B. J. (1998) · AIDS · doi:10.1097/00002030-199804000-00003 · Cited by 132 · see citing works

Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

Shepard, P. D., Joy, B., Prendeville, L. C., & Schwarcz, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300188 · Cited by 131 · see citing works

Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.

Sapko, M. T., Guidetti, P., Yu, P., Tagle, D., Pellicciari, R., & Schwarcz, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.004 · Cited by 127 · see citing works

Synthesis of Quinolinic Acid by 3‐Hydroxyanthranilic Acid Oxygenase in Rat Brain Tissue In Vitro

Foster, A. C., White, R. J., & Schwarcz, R. M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb02826.x · Cited by 126 · see citing works

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

Bonda, D., Mailankot, M., Stone, J. G., Garrett, M. R., Staniszewska, M. M., Castellani, R. J., Siedlak, S. L., Zhu, X., Lee, H., Perry, G. L., et al. (2010) · Redox Report · doi:10.1179/174329210x12650506623645 · Cited by 125 · see citing works

Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders

Oxenkrug, G. (2010) · Journal of neural transmission · doi:10.1007/s00702-010-0475-7 · Cited by 121 · see citing works

Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release

Zmarowski, A., Wu, H., Brooks, J. M., Potter, M. C., Pellicciari, R., Schwarcz, R. M., & Bruno, J. P. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06594.x · Cited by 121 · see citing works

Kynurenine Pathway Enzymes in Brain: Responses to Ischemic Brain Injury Versus Systemic Immune Activation

Saito, K., Nowak, T. S., Suyama, K., Quearry, B. J., Saito, M., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07443.x · Cited by 116 · see citing works

Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat.

Foster, A., Miller, L., Oldendorf, W., & Schwarcz, R. (1984) · Experimental Neurology · doi:10.1016/0014-4886(84)90239-5 · Cited by 114 · see citing works

L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning

Chess, A. C., Landers, A., & Bucci, D. J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.013 · Cited by 113 · see citing works

Peripheral and cerebral metabolic abnormalities of the tryptophan–kynurenine pathway in a murine model of major depression

Laugeray, A., Launay, J., Callebert, J., Surget, A., Belzung, C., & Barone, P. R. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.014 · Cited by 113 · see citing works

Kynurenine pathway metabolism in human blood–brain–barrier cells: implications for immune tolerance & neurotoxicity

Owe‐Young, R., Webster, N. L., Mukhtār, M., Pomerantz, R. J., Smythe, G. A., Walker, D. W., Armati, P. J., Crowe, S. M., & Brew, B. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05241.x · Cited by 112 · see citing works

Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.

Olsson, S., Samuelsson, M., Saetre, P., Lindström, L., Jönsson, E. G., Nordin, C., Engberg, G., Erhardt, S., & Landén, M. (2010) · Journal of Psychiatry & Neuroscience · doi:10.1503/jpn.090180 · Cited by 110 · see citing works

Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege

Huang, L., Baban, B., Johnson, B. A., & Mellor, A. L. (2010) · International Reviews of Immunology · doi:10.3109/08830180903349669 · Cited by 110 · see citing works

Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis

Guillemin, G. J., Smith, D. G., Kerr, S. J., Smythe, G. A., Kapoor, V., Armati, P. J., & Brew, B. J. (2000) · Redox Report · doi:10.1179/135100000101535375 · Cited by 108 · see citing works

Uptake of Kynurenine into Rat Brain Slices

Speciale, C., & Schwarcz, R. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb13296.x · Cited by 106 · see citing works

Similarities and differences in the neuronal death processes activated by 3OH‐kynurenine and quinolinic acid

Chiarugi, A., Meli, E., & Moroni, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00335.x · Cited by 106 · see citing works

PRE- AND POSTNATAL EXPOSURE TO KYNURENINE CAUSES COGNITIVE DEFICITS IN ADULTHOOD

Pocivavsek, A., Wu, H., Elmer, G. I., Bruno, J. P., & Schwarcz, R. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08064.x · Cited by 105 · see citing works

Brain‐Specific Modulation of Kynurenic Acid Synthesis in the Rat

Gramsbergen, J. B., Hodgkins, P., Rassoulpour, A., Turski, W. A., Guidetti, P., & Schwarcz, R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010290.x · Cited by 105 · see citing works

Comparison of the Neurochemical and Behavioral Effects Resulting from the Inhibition of Kynurenine Hydroxylase and/or Kynureninase

Chiarugi, A., Carpenedo, R., Molina, M. T., Mattoli, L., Pellicciari, R., & Moroni, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031176.x · Cited by 105 · see citing works

(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats

Speciale, C., Wu, H., Cini, M., Marconi, M., Varasi, M., & Schwarcz, R. M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00613-9 · Cited by 104 · see citing works

Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats

Stone, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05540.x · Cited by 103 · see citing works

Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum

Amori, L., Wu, H., Marinozzi, M., Pellicciari, R., Guidetti, P., & Schwarcz, R. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.055 · Cited by 101 · see citing works

Quinolinic acid — Iron(II) complexes: Slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction

Plátenı́k, J., Stopka, P., Vejražka, M., & Štípek, S. (2001) · Free Radical Research · doi:10.1080/10715760100300391 · Cited by 100 · see citing works

Kynurenines, Parkinson’s disease and other neurodegenerative disorders: preclinical and clinical studies

Németh, H., Toldi, J., & Vécsei, L. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_45 · Cited by 99 · see citing works

Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment

Giorgini, F., Möller, T., Kwan, W., Zwilling, D., Wacker, J. L., Hong, S. Y., Tsai, L. L., Cheah, C. S., Schwarcz, R. M., Guidetti, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708192200 · Cited by 97 · see citing works

Early kynurenergic impairment in Huntington's Disease and in a transgenic animal model

Guidetti, P., Reddy, P. H., Tagle, D. A., & Schwarcz, R. M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00956-3 · Cited by 97 · see citing works

The effect of quinolinate on rat brain lipid peroxidation is dependent on iron

Štípek, S., Šťastný, F., Plátenı́k, J., Crkovska, J., & Zima, T. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(97)90002-4 · Cited by 97 · see citing works

Electrochemical and in vitro evaluation of the redox-properties of kynurenine species

Giles, G. I., Collins, C. A., Stone, T. W., & Jacob, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02917-0 · Cited by 96 · see citing works

Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

Prendergast, G. C., Chang, M. Y., Mandik‐Nayak, L., Metz, R. A., & Muller, A. J. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795656072 · Cited by 96 · see citing works

Prolonged Survival of a Murine Model of Cerebral Malaria by Kynurenine Pathway Inhibition

Clark, C. J., Mackay, G., Smythe, G. A., Bustamante, S., Stone, T. W., & PHILLIPS, R. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.5249-5251.2005 · Cited by 96 · see citing works

Metabolism of [5‐3H]Kynurenine in the Rat Brain In Vivo: Evidence for the Existence of a Functional Kynurenine Pathway

Guidetti, P., Eastman, C. L., & Schwarcz, R. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062621.x · Cited by 94 · see citing works

Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys

Grégoire, L., Rassoulpour, A., GUIDETTI, P., Samadi, P., BEDARD, P., Izzo, E., Schwarcz, R. M., & Paolo, T. D. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.007 · Cited by 91 · see citing works

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

Erhardt, S., & Engberg, G. (2002) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2002.00962.x · Cited by 91 · see citing works

Nicotinylalanine Increases the Formation of Kynurenic Acid in the Brain and Antagonizes Convulsions

Russi, P., Alesiani, M., Lombardi, G., Davolio, P. L., Pellicciari, R., & Moroni, F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10097.x · Cited by 89 · see citing works

Effects of Kynurenine Pathway Inhibition on NAD+ Metabolism and Cell Viability in Human Primary Astrocytes and Neurons

Braidy, N., Guillemin, G., & Grant, R. (2011) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s7052 · Cited by 87 · see citing works

Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors

Fazio, F., Lionetto, L., Molinaro, G., Bertrand, H., Acher, F., Ngomba, R. T., Notartomaso, S., Curini, M., Rosati, O., Scarselli, P., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.074765 · Cited by 86 · see citing works

Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C

Smith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84 · see citing works

Kynurenic Acid: A Potential Pathogen in Brain Disordersa

Schwarcz, R. M., Du, F., Schmidt, W., Turski, W. A., Gramsbergen, J. B., Okuno, E., & Roberts, R. C. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24532.x · Cited by 80 · see citing works

Competitive Antagonism between the Nicotinic Allosteric Potentiating Ligand Galantamine and Kynurenic Acid at α7* Nicotinic Receptors

Lopes, C., Pereira, E. F. R., Wu, H., Purushottamachar, P., Njar, V. C. O., Schwarcz, R. M., & Albuquerque, E. X. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123109 · Cited by 79 · see citing works

Modulators of the Kynurenine Pathway of Tryptophan Metabolism: Synthesis and Preliminary Biological Evaluation of ( S )‐4‐(Ethylsulfonyl)benzoylalanine, a Potent and Selective Kynurenine Aminotransferase II (KAT II) Inhibitor

Pellicciari, R., Rizzo, R. C., Costantino, G., Marinozzi, M., Amori, L., Guidetti, P., Wu, H., & Schwarcz, R. M. (2006) · ChemMedChem · doi:10.1002/cmdc.200500095 · Cited by 78 · see citing works

Tissue expression and biochemical characterization of human 2‐amino 3‐carboxymuconate 6‐semialdehyde decarboxylase, a key enzyme in tryptophan catabolism

Pucci, L., Perozzi, S., Cimadamore, F., Orsomando, G., & Raffaelli, N. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05635.x · Cited by 78 · see citing works

Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues

Kohl, C. A., Walch, T., Huber, R., Kemmler, G., Neurauter, G., Fuchs, D., Sölder, E., Schröcksnadel, H., & Sperner‐Unterweger, B. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.013 · Cited by 77 · see citing works

Heme: A Regulator of Rat Hepatic Tryptophan 2,3-Dioxygenase?

Ren, S., & Correia, M. A. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1755 · Cited by 76 · see citing works

Biochemical and Phenotypic Abnormalities in Kynurenine Aminotransferase II-Deficient Mice

Yü, P., Prospero, N. A. D., Sapko, M. T., Cai, T., Chen, A., Meléndez‐Ferro, M., Du, F., Whetsell, W. O., Guidetti, P., Schwarcz, R. M., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.6919-6930.2004 · Cited by 76 · see citing works

Quinolinic Acid Phosphoribosyltransferase in Rat Brain

Foster, A. C., Zinkand, W. C., & Schwarcz, R. M. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05435.x · Cited by 75 · see citing works

Presence of 3‐Hydroxyanthranilic Acid in Rat Tissues and Evidence for Its Production from Anthranilic Acid in the Brain

Baran, H., & Schwarcz, R. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04553.x · Cited by 74 · see citing works

Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3

Uwai, Y., Honjo, H., & Iwamoto, K. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.11.003 · Cited by 74 · see citing works

Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels

Mok, M. H. S., Fricker, A.-C., Weil, A., & Kew, J. N. C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.003 · Cited by 74 · see citing works

Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus—infected rhesus macaques: Relationship to clinical and viral status

Heyes, M. P., Mefford, I. N., Quearry, B. J., Dedhia, M., & Lackner, A. A. (1990) · Annals of Neurology · doi:10.1002/ana.410270614 · Cited by 73 · see citing works

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain

Ceresoli‐Borroni, G., Rassoulpour, A., Wu, H., Guidetti, P., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0432-z · Cited by 72 · see citing works

Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway.

Dang, Y.-H., Dale, W. E., & Brown, O. R. (2000) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(99)00272-5 · Cited by 72 · see citing works

Xanthurenic acid distribution, transport, accumulation and release in the rat brain

Gobaille, S., Kemmel, V., Brumaru, D., Dugave, C., Aunis, D., & Maître, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05219.x · Cited by 72 · see citing works

Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

Erhardt, S., Öberg, H., Mathé, J. M., & Engberg, G. (2001) · Amino Acids · doi:10.1007/s007260170032 · Cited by 69 · see citing works

Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis

Rodgers, J., Stone, T. W., Barrett, M. P., Bradley, B., & Kennedy, P. G. E. (2009) · Brain · doi:10.1093/brain/awp074 · Cited by 69 · see citing works

Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: Up-regulation by inflammatory stimuli and with clinical infection

Manuelpillai, U., Ligam, P., Smythe, G. A., Wallace, E. M., Hirst, J. J., & Walker, D. W. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.090 · Cited by 65 · see citing works

Ueber Kynurensäure

Liebig, J. (1853) · Justus Liebig s Annalen der Chemie · doi:10.1002/jlac.18530860115 · Cited by 65 · see citing works

Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity

Connick, J. H., Heywood, G. C., Sills, G. J., Thompson, G., Brodie, M. J., & Stone, T. W. (1992) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(92)90017-e · Cited by 61 · see citing works

Kynurenines as Probable Participants of Depression

Lapin, I. P. (1973) · Pharmacopsychiatry · doi:10.1055/s-0028-1094391 · Cited by 61 · see citing works

Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate

Hodgkins, P., & Schwarcz, R. M. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00208.x · Cited by 59 · see citing works

Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: Effect of aminooxyacetic acid

Speciale, C., Wu, H., Gramsbergen, J. B., Turski, W. A., Ungerstedt, U., & Schwarcz, R. M. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90410-b · Cited by 59 · see citing works

Indole-3-Pyruvic and -Propionic Acids, Kynurenic Acid, and Related Metabolites as Luminophores and Free-Radical Scavengers

Hardeland, R., Zsizsik, B. K., Pöeggeler, B., Fuhrberg, B., Holst, S., & Coto‐Montes, A. M. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_49 · Cited by 59 · see citing works

Actions of Xanthurenic Acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus

Copeland, C. S., Neale, S. A., & Salt, T. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.009 · Cited by 55 · see citing works

α-Methyl- L -Tryptophan: Mechanisms for Tracer Localization of Epileptogenic Brain Regions

Chugani, D. C. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.73 · Cited by 54 · see citing works

Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: A pharmacological analysis

Linderholm, K. R., Andersson, A., Olsson, S. K., Olsson, E., Snodgrass, R., Engberg, G., & Erhardt, S. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.09.003 · Cited by 50 · see citing works

Metabolism of Tryptophan in Depressive Disease

Frazer, A. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200040070012 · Cited by 50 · see citing works

Exposure to Kynurenic Acid During Adolescence Produces Memory Deficits in Adulthood

Akagbosu, C., Evans, G. C., Gulick, D., Suckow, R. F., & Bucci, D. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq151 · Cited by 50 · see citing works

Metabolism of 6-chlorotryptophan to 4-chloro-3-hydroxyanthranilic acid: A potent inhibitor of 3-hydroxyanthranilic acid oxidase

Parli, C. J., Krieter, P. A., & Schmidt, B. K. (1980) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(80)90164-2 · Cited by 49 · see citing works

Seizure activity causes elevation of endogenous extracellular kynurenic acid in the rat brain

Wu, H., & Schwarcz, R. M. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02087-x · Cited by 47 · see citing works

Association study between kynurenine 3‐monooxygenase gene and schizophrenia in the Japanese population

Aoyama, N., Takahashi, N., Saito, S., Maeno, N., Ishihara, R., Ji, X., Miura, H., Ikeda, M., Suzuki, T., Kitajima, T., et al. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00231.x · Cited by 46 · see citing works

Modulation of the function of presynaptic α7 and non‐α7 nicotinic receptors by the tryptophan metabolites, 5‐hydroxyindole and kynurenate in mouse brain

Grilli, M., Raiteri, L., Patti, L., Parodi, M., Robino, F., Raiteri, M., & Marchi, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706914 · Cited by 46 · see citing works

Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats

Speciale, C., Ungerstedt, U., & Schwarcz, R. M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90601-0 · Cited by 43 · see citing works

Organ Distribution of Rat Kynureninase and Changes of Its Activity during Development

Kawai, J., Okuno, E., & Kido, R. (2017) · Enzyme · doi:10.1159/000469117 · Cited by 43 · see citing works

Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain

Rassoulpour, A., Wu, H.-Q., Pöeggeler, B., & Schwarcz, R. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00577-0 · Cited by 42 · see citing works

Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats

Baran, H., Gramer, M., Hönack, D., & Löscher, W. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00443-o · Cited by 42 · see citing works

On the Production and Disposition of Quinolinic Acid in Rat Brain and Liver Slices

Speciale, C., & Schwarcz, R. M. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05840.x · Cited by 42 · see citing works

Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.

Chiarugi, A., & Moroni, F. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00048-9 · Cited by 40 · see citing works

Glial activation precedes seizures and hippocampal neurodegeneration in measles virus–infected mice

Lehrmann, E., Guidetti, P., Löve, A., Williamson, J., Bertram, E. H., & Schwarcz, R. M. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01489.x · Cited by 39 · see citing works

Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum

Lehrmann, E., Molinari, A., Speciale, C., & Schwarcz, R. (2001) · Experimental Brain Research · doi:10.1007/s002210100887 · Cited by 38 · see citing works

2‐Oxoacids Regulate Kynurenic Acid Production in the Rat Brain

Hodgkins, P., Wu, H., Zielke, R. H., & Schwarcz, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720643.x · Cited by 36 · see citing works

ChemInform Abstract: Synthesis and Biochemical Evaluation of N‐(4‐Phenylthiazol‐2‐yl)benzenesulfonamides as High‐Affinity Inhibitors of Kynurenine 3‐Hydroxylase.

Roever, S., Cesura, A. M., Huguenin, P. N., Kettler, R., & Szente, A. (1998) · ChemInform · doi:10.1002/chin.199820156 · Cited by 34 · see citing works

Ecni GC-MS Analysis of Picolinic and Quinolinic Acids and Their Amides in Human Plasma, CSF, and Brain Tissue

Smythe, G. A., Poljak, A., Bustamante, S., Braga, O., Maxwell, A., Grant, R., & Sachdev, P. S. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_83 · Cited by 33 · see citing works

Perinatal kynurenine 3‐hydroxylase inhibition in rodents: Pathophysiological implications

Ceresoli‐Borroni, G., Guidetti, P., Amori, L., Pellicciari, R., & Schwarcz, R. M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21183 · Cited by 32 · see citing works

Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury

Blight, A. R., Saito, K., & Heyes, M. P. (1993) · Brain Research · doi:10.1016/0006-8993(93)91167-q · Cited by 32 · see citing works

Impaired Dexamethasone-Mediated Induction of Tryptophan 2,3-Dioxygenase in Heme-Deficient Rat Hepatocytes: Translational Control by a Hepatic eIF2α Kinase, the Heme-Regulated Inhibitor

Liao, M., Pabarcus, M. K., Wang, Y., Hefner, C., Maltby, D., Medzihradszky, K., Salas-Castillo, S. P., Yan, J. S., Maher, J., & Correia, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124602 · Cited by 32 · see citing works

Administration of kynurenine during adolescence, but not during adulthood, impairs social behavior in rats

Batterman, K. V., & Bucci, D. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.08.014 · Cited by 30 · see citing works

2-Amino-4-[3′-hydroxyphenyl]-4-hydroxybutanoic acid; A potent inhibitor of rat and recombinant human kynureninase

Walsh, H. A., Leslie, P. L., O'Shea, K. C., & Botting, N. P. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00758-2 · Cited by 29 · see citing works

Neonatal Asphyxia in Rats: Acute Effects on Cerebral Kynurenine Metabolism

Ceresoli‐Borroni, G., & Schwarcz, R. M. (2001) · Pediatric Research · doi:10.1203/00006450-200108000-00011 · Cited by 28 · see citing works

The Microbiota-Gut-Brain Axis

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · see citing works

From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.

Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206 · see citing works

Serotonin, tryptophan metabolism and the brain-gut-microbiome axis

O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.027 · Cited by 2,012 · see citing works

Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat

Kelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683 · see citing works

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586 · see citing works

Human gut microbiota/microbiome in health and diseases: a review

Gomaa, E. Z. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01474-7 · Cited by 1,294 · see citing works

Physical activity and depression: towards understanding the antidepressant mechanisms of physical activity

Kandola, A., Ashdown-Franks, G., Hendrikse, J., Sabiston, C. M., & Stubbs, B. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.040 · Cited by 1,309 · see citing works

Minireview: Gut microbiota: The neglected endocrine organ

Clarke, G., Stilling, R. M., Kennedy, P. J., Stanton, C., Cryan, J. F., & Dinan, T. G. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1108 · Cited by 1,192 · see citing works

Neuroinflammation and depression: A review

Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107 · see citing works

From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways

Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969 · see citing works

Metabolic Interactions in the Tumor Microenvironment

Lyssiotis, C. A., & Kimmelman, A. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.003 · Cited by 853 · see citing works

Physical activity and muscle-brain crosstalk

Pedersen, B. K. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0174-x · Cited by 772 · see citing works

The kynurenine pathway: a finger in every pie

Savitz, J. B. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0414-4 · Cited by 774 · see citing works

Skeletal Muscle PGC-1α1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression

Agudelo, L. Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.051 · Cited by 739 · see citing works

Kynurenine pathway metabolism and the microbiota-gut-brain axis

Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724 · see citing works

Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health

Parker, A., Fonseca, S., & Carding, S. R. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1638722 · Cited by 722 · see citing works

Kynurenines in the CNS: recent advances and new questions

Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641 · see citing works

Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis

Mittal, R., Debs, L. H., Patel, A. P., Nguyen, D., Patel, K. V., O’Connor, G., Grati, M., Mittal, J., Yan, D. L. S., Eshraghi, A. A., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25518 · Cited by 644 · see citing works

Inflammation, glutamate, and glia: a trio of trouble in mood disorders

Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584 · see citing works

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

Sadik, A., Patterson, L. F. S., Öztürk, S., Mohapatra, S. R., Panitz, V., Secker, P. F., Pfänder, P., Loth, S., Salem, H., Prentzell, M. T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.038 · Cited by 563 · see citing works

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis

Westfall, S., Lomis, N., Kahouli, I., Dia, S. Y., Singh, S. P., & Prakash, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2550-9 · Cited by 551 · see citing works

Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota

Karl, J. P., Hatch‐McChesney, A., Arcidiacono, S. M., Pearce, S., Pantoja-Feliciano, I. G., Doherty, L. A., & Soares, J. W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02013 · Cited by 535 · see citing works

Flavin dependent monooxygenases

Huijbers, M. M. E., Montersino, S., Westphal, A. H., Tischler, D., & van Berkel, W. J. H. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.005 · Cited by 529 · see citing works

The role of inflammation and the gut microbiome in depression and anxiety

Peirce, J. M., & Alviña, K. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24476 · Cited by 466 · see citing works

Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health

Berding, K., Vlckova, K., Marx, W., Schellekens, H., Stanton, C., Clarke, G., Jacka, F., Dinan, T. G., & Cryan, J. F. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa181 · Cited by 451 · see citing works

Kynurenines in CNS disease: regulation by inflammatory cytokines.

Campbell, B. M., Charych, E., Lee, A. W., & Möller, T. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00012 · Cited by 409 · see citing works

Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis

Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415 · see citing works

Rheumatoid arthritis and depression: an inflammatory perspective

Nerurkar, L., Siebert, S., McInnes, I. B., & Cavanagh, J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30255-4 · Cited by 417 · see citing works

Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise

Felger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 394 · see citing works

Gut microbial molecules in behavioural and neurodegenerative conditions

Needham, B. D., Kaddurah-Daouk, R., & Mazmanian, S. K. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00381-0 · Cited by 379 · see citing works

Microbiota alteration is associated with the development of stress-induced despair behavior

Marin, I. A., Goertz, J. E., Ren, T., Rich, S. S., Onengut-Gumuscu, S., Farber, E., Wu, M., Overall, C. C., Kipnis, J., & Gaultier, A. (2017) · Scientific Reports · doi:10.1038/srep43859 · Cited by 369 · see citing works

Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target

Sorgdrager, F. J. H., Naudé, P. J. W., Kema, I. P., Nollen, E. A. A., & Deyn, P. P. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02565 · Cited by 372 · see citing works

Tryptophan-kynurenine pathway is dysregulated in inflammation and immune activation

Zou, M. (2015) · Frontiers in bioscience · doi:10.2741/4363 · Cited by 361 · see citing works

Development of Halogenase Enzymes for Use in Synthesis

Latham, J., Brandenburger, E., Shepherd, S. A., Menon, B. R. K., & Micklefield, J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00032 · Cited by 351 · see citing works

Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain

Deng, Y., Zhou, M., Wang, J., Yao, J., Yu, J., Liu, W., Wu, L., Wang, J., & Gao, R. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1869501 · Cited by 362 · see citing works

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

Fernandes, B. S., Steiner, J., Bernstein, H.-G., Dodd, S., Pasco, J. A., Dean, O. M., Nardin, P., Gonçalves, C.-A., & Berk, M. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.87 · Cited by 348 · see citing works

Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

Millan, M. J., Fone, K. C. F., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 354 · see citing works

Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans

Palego, L., Betti, L., Rossi, A., & Giannaccini, G. (2016) · Journal of Amino Acids · doi:10.1155/2016/8952520 · Cited by 349 · see citing works

Connecting inflammation with glutamate agonism in suicidality

Erhardt, S., Lim, C. K., Linderholm, K. R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T. T., Träskman-Bendz, L., Guillemin, G. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.248 · Cited by 345 · see citing works

Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice

Zhu, F., Guo, R., Wang, W., Ju, Y., Wang, Q., Ma, Q., Sun, Q., Fan, Y., Xie, Y., Yang, Z., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0475-4 · Cited by 323 · see citing works

How important is tryptophan in human health?

Kałużna-Czaplińska, J., Gątarek, P., Chirumbolo, S., Chartrand, M. S., & Bjørklund, G. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1357534 · Cited by 333 · see citing works

Irritable bowel syndrome: A microbiome-gut-brain axis disorder?

Kennedy, P. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14105 · Cited by 335 · see citing works

The Impact of Microbiota on Brain and Behavior: Mechanisms & Therapeutic Potential

Borre, Y. E., Moloney, R. D., Clarke, G., Dinan, T. G., & Cryan, J. F. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_17 · Cited by 329 · see citing works

The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective

Cussotto, S., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.04.002 · Cited by 326 · see citing works

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies

Marx, W., McGuinness, A. J., Rocks, T., Ruusunen, A. A., Cleminson, J. R., Walker, A. J., Gomes‐da‐Costa, S., Lane, M. M., Sanches, M., Díaz, A. P., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00951-9 · Cited by 327 · see citing works

Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis

Manjaly, Z., Harrison, N. A., Critchley, H., Tri, C., Stefanics, G., Wenderoth, N., Lutterotti, A., Müller, A. E., & Stephan, K. E. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320050 · Cited by 329 · see citing works

Tryptophan Metabolism by Gut Microbiome and Gut-Brain-Axis: An in silico Analysis

Kaur, H., Bose, C., & Mande, S. S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01365 · Cited by 320 · see citing works

The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease

Morris, G., Berk, M., Carvalho, A. F., Caso, J. R., Sanz, Y., Walder, K. R., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 307 · see citing works

A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality

Bay-Richter, C., Linderholm, K. R., Lim, C. K., Samuelsson, M., Träskman-Bendz, L., Guillemin, G. J., Erhardt, S., & Brundin, L. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.012 · Cited by 304 · see citing works

Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation

Agudelo, L. Z., Ferreira, D. M. S., Červenka, I., Bryzgalova, G., Dadvar, S., Jannig, P. R., Pettersson-Klein, A. T., Lakshmikanth, T., Sustarsic, E. G., Porsmyr‐Palmertz, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.004 · Cited by 304 · see citing works

May the Force Be With You: The Light and Dark Sides of the Microbiota–Gut–Brain Axis in Neuropsychiatry

Sherwin, E., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0370-3 · Cited by 297 · see citing works

Tryptophan in health and disease

Comai, S., Bertazzo, A., Brughera, M., & Crotti, S. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 300 · see citing works

Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection

Shandilya, S., Kumar, S., Jha, N. K., Kesari, K. K., & Ruokolainen, J. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.09.005 · Cited by 300 · see citing works

Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia

Kindler, J., Lim, C. K., Weickert, C., Boerrigter, D., Galletly, C., Liu, D., Jacobs, K. R., Balzan, R., Bruggemann, J. M., O'Donnell, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0401-9 · Cited by 267 · see citing works

The NMDA Receptor and Schizophrenia

Balu, D. T. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 285 · see citing works

Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan

Castro-Portuguez, R., & Sutphin, G. L. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110841 · Cited by 282 · see citing works

The relationship between nutrition and the immune system

Munteanu, C., & Schwartz, B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1082500 · Cited by 315 · see citing works

Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume

Fillman, S. G., Weickert, T. W., Lenroot, R. K., Catts, S. V., Bruggemann, J. M., Catts, V. S., & Weickert, C. S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.90 · Cited by 270 · see citing works

The origin of NMDA receptor hypofunction in schizophrenia

Nakazawa, K., & Sapkota, K. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107426 · Cited by 277 · see citing works

Cross talk: the microbiota and neurodevelopmental disorders

Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00490 · Cited by 271 · see citing works

Endocrine Crosstalk Between Skeletal Muscle and the Brain

Delezie, J., & Handschin, C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00698 · Cited by 270 · see citing works

Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder

Savitz, J., Drevets, W. C., Smith, C. M., Victor, T. A., Wurfel, B. E., Bellgowan, P. S., Bodurka, J., Teague, T. K., & Dantzer, R. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.194 · Cited by 272 · see citing works

The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments

Kim, Y., & Shin, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915141036 · Cited by 273 · see citing works

Brain–gut–microbiome interactions in obesity and food addiction

Gupta, A., Osadchiy, V., & Mayer, E. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0341-5 · Cited by 268 · see citing works

Immune aging, dysmetabolism, and inflammation in neurological diseases

Deleidi, M., Jäggle, M., & Rubino, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00172 · Cited by 260 · see citing works

Role of Inflammation in Suicide: From Mechanisms to Treatment

Brundin, L., Bryleva, E. Y., & Thirtamara Rajamani, K. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.116 · Cited by 257 · see citing works

Understanding the Role of Systemic Inflammation in Alzheimer’s Disease

Walker, K. A., Ficek, B. N., & Westbrook, R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00333 · Cited by 259 · see citing works

The kynurenine pathway in schizophrenia and bipolar disorder

Erhardt, S., Schwieler, L., Imbeault, S., & Engberg, G. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.020 · Cited by 257 · see citing works

Insulin Resistance and Dysregulation of Tryptophan–Kynurenine and Kynurenine–Nicotinamide Adenine Dinucleotide Metabolic Pathways

Oxenkrug, G. F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8497-4 · Cited by 255 · see citing works

Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis

Plitman, E., Iwata, Y., Caravaggio, F., Nakajima, S., Chung, J. K., Gerretsen, P., Kim, J., Takeuchi, H., Chakravarty, M. M., Remington, G. J., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw221 · Cited by 252 · see citing works

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway

Tanaka, M., Tóth, F., Polyák, H., Szabó, Á., Mándi, Y., & Vécsei, L. (2021) · Biomedicines · doi:10.3390/biomedicines9070734 · Cited by 252 · see citing works

Gut microbiota–brain axis in depression: the role of neuroinflammation

Carlessi, A. S., Borba, L. A., Zugno, A. I., Quevedo, J., & Réus, G. Z. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14631 · Cited by 243 · see citing works

Progress and Challenges in the Biology of FNDC5 and Irisin

Maak, S., Norheim, F., Drevon, C. A., & Erickson, H. P. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab003 · Cited by 247 · see citing works

Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches

Dantzer, R. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_6 · Cited by 248 · see citing works

Obesity and gut–microbiota–brain axis: A narrative review

Asadi, A., Mehr, N. S., Mohamadi, M. H., Shokri, F., Heidary, M., Sadeghifard, N., & Khoshnood, S. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24420 · Cited by 254 · see citing works

Role of indoleamine 2,3-dioxygenase in health and disease

Yeung, A. W. S., Terentis, A. C., King, N. J. C., & Thomas, S. R. (2015) · Clinical Science · doi:10.1042/cs20140392 · Cited by 235 · see citing works

The Uniqueness of Tryptophan in Biology: Properties, Metabolism, Interactions and Localization in Proteins

Barik, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228776 · Cited by 233 · see citing works

The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia

Cohen, S. M., Tsien, R. W., GOFF, D. C., & Halassa, M. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.026 · Cited by 233 · see citing works

Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease

Chen, L.-M., Bao, C., Wu, Y. H., Liang, S.-H., Wang, D., Wu, L.-Y., Huang, Y., Liu, H.-R., & Wu, H.-G. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02175-2 · Cited by 239 · see citing works

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia — significance for activation of the kynurenine pathway

Schwieler, L., Larsson, M. K., Skogh, E., Kegel, M. E., Orhan, F., Abdelmoaty, S., Finn, A., Bhat, M., Samuelsson, M., Lundberg, K., et al. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140126 · Cited by 224 · see citing works

Tryptophan metabolites along the microbiota-Gut-Brain axis: an interkingdom communication system influencing the gut in health and disease

Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920928984 · Cited by 221 · see citing works

Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets

Kouba, B. R., Borba, L. A., de Souza, P. B., Gil‐Mohapel, J., & Rodrigues, A. L. S. (2024) · Cells · doi:10.3390/cells13050423 · Cited by 232 · see citing works

Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells

Wang, G., Cao, K., Liu, K., Xue, Y., Roberts, A. I., Li, F., Han, Y., Rabson, A. B., Wang, Y., & Shi, Y. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0006-2 · Cited by 214 · see citing works

Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain–Gut–Microbiome Axis

Chudzik, A., Orzyłowska, A., Rola, R., & Stanisz, G. J. (2021) · Biomolecules · doi:10.3390/biom11071000 · Cited by 212 · see citing works

Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder

Savitz, J. B., Drevets, W. C., Wurfel, B. E., Ford, B. N., Bellgowan, P. S. F., Victor, T. A., Bodurka, J., Teague, T. K., & Dantzer, R. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.007 · Cited by 207 · see citing works

Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia

Connell, E., Le Gall, G., Pontifex, M. G., Sami, S., Cryan, J. F., Clarke, G., Müller, M., & Vauzour, D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00548-6 · Cited by 208 · see citing works

The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond

Balu, D. T., & Coyle, J. T. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.004 · Cited by 208 · see citing works

Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice

Walker, A. K., Wing, E. E., Banks, W. A., & Dantzer, R. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0076-7 · Cited by 206 · see citing works

The Role of Tryptophan Dysmetabolism and Quinolinic Acid in Depressive and Neurodegenerative Diseases

Hestad, K. A., Alexander, J., Rootwelt, H., & Aaseth, J. (2022) · Biomolecules · doi:10.3390/biom12070998 · Cited by 206 · see citing works

What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics?

Davis, I., & Liu, A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1049999 · Cited by 200 · see citing works

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children

Bahr, S. M., Tyler, B. C., Wooldridge, N., Butcher, B. D., Burns, T. L., Teesch, L. M., Oltman, C. L., Azcarate-Peril, M. A., Kirby, J. R., & Calarge, C. A. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.135 · Cited by 197 · see citing works

Physical Activity and Diet Shape the Immune System during Aging

Weyh, C., Krüger, K., & Strasser, B. (2020) · Nutrients · doi:10.3390/nu12030622 · Cited by 202 · see citing works

An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation

Brundin, L., Sellgren, C. M., Lim, C. K., Grit, J., Pålsson, E., Landén, M., Samuelsson, M., Lundgren, K., Brundin, P., Fuchs, D., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.133 · Cited by 195 · see citing works

The aryl hydrocarbon receptor as a mediator of host-microbiota interplay

Dong, F., & Perdew, G. H. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1859812 · Cited by 193 · see citing works

Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease

Czapski, G. A., & Strosznajder, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111677 · Cited by 194 · see citing works

Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications

Olloquequi, J., Cornejo-Córdova, E., Verdaguer, E., Soriano, F. X., Binvignat, O., Auladell, C., & Camins, A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754680 · Cited by 190 · see citing works

Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications

Mithaiwala, M. N., Santana-Coelho, D., Porter, G. A., & O’Connor, J. C. (2021) · Cells · doi:10.3390/cells10061548 · Cited by 190 · see citing works

Immunomodulatory Effects Mediated by Serotonin

Arreola, R., Becerril-Villanueva, E., Cruz-Fuentes, C., Velasco-Velázquez, M., Garcés-Alvarez, M. E., Hurtado-Alvarado, G., Quintero-Fabián, S., & Pavón, L. (2015) · Journal of Immunological Research · doi:10.1155/2015/354957 · Cited by 190 · see citing works

The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function

Sinkus, M. L., Graw, S. L., Freedman, R., Ross, R. G., Lester, H. A., & Leonard, S. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.006 · Cited by 186 · see citing works

The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies

Pathak, S., Nadar, R. M., Kim, S., Liu, K., Govindarajulu, M., Cook, P., Alexander, C. S. W., Dhanasekaran, M., & Moore, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020853 · Cited by 90 · see citing works

The kynurenine pathway of tryptophan degradation as a drug target

Schwarcz, R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.006 · Cited by 265 · see citing works

KYNURENINES IN PATHOGENESIS OF ENDOGENOUS PSYCHIATRIC DISORDERS

Shilov, Y., & Mv, B. (2013) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v68i1.535 · Cited by 11 · see citing works

The kynurenine pathway and neurodegenerative disease

Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309 · see citing works

Kynurenines in the CNS: recent advances and new questions

Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641 · see citing works